Author
Listed:
- Jette A. Lint
(Netherlands Pharmacovigilance Centre Lareb
Radboudumc)
- Marlieke Sonnenberg
(Netherlands Pharmacovigilance Centre Lareb)
- Harald E. Vonkeman
(Medisch Spectrum Twente
University of Twente)
- Bart J. F. Bemt
(Radboudumc
Sint Maartenskliniek)
- Eugene P. Puijenbroek
(Netherlands Pharmacovigilance Centre Lareb
University of Groningen)
- Naomi T. Jessurun
(Netherlands Pharmacovigilance Centre Lareb)
Abstract
Introduction There is a need for more extensive information about adverse drug reactions (ADRs) for patients than currently available, including information on the course of ADRs. Aspects characterising the course of ADRs from the patient perspective have not been identified before. Objective We aimed to develop a framework based on common themes in the course of ADRs identified from patient descriptions in patient-reported ADRs. Methods In this qualitative study, patient descriptions of the course of patient-reported ADRs were analysed by a thematic analysis with an inductive approach using three different existing datasets containing patient-reported ADRs. Two datasets included patient-reported ADRs from cohort event monitoring of biologics and direct oral anticoagulants and one dataset included spontaneous reports from patients concerning medication for lower urinary tract symptoms. A conceptual framework was developed from the identified main themes and subthemes. Results Patient-reported data concerning 3888 ADRs were analysed. Six main themes with multiple subthemes were identified from patient descriptions of the course of ADRs. Four themes were descriptive: frequency of an ADR episode, duration of an ADR episode, moment or period of ADR occurrence, and development in the intensity of the ADR. Two themes concerned factors influencing the course of ADRs: triggering factors and improving factors. Conclusions The presented framework illustrates that patients describe extensive details on the course and timeframe of ADRs. The identified themes provide a basis for improving the systematic data collection of more extensive details about ADRs from patients as a first step towards the provision of more comprehensive ADR information to patients.
Suggested Citation
Jette A. Lint & Marlieke Sonnenberg & Harald E. Vonkeman & Bart J. F. Bemt & Eugene P. Puijenbroek & Naomi T. Jessurun, 2023.
"Development of a Framework Structuring Themes in the Course of Adverse Drug Reactions from a Patient’s Perspective,"
Drug Safety, Springer, vol. 46(10), pages 1039-1047, October.
Handle:
RePEc:spr:drugsa:v:46:y:2023:i:10:d:10.1007_s40264-023-01343-y
DOI: 10.1007/s40264-023-01343-y
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:46:y:2023:i:10:d:10.1007_s40264-023-01343-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.